DelveInsight's Acromegaly and gigantism therapeutics market insight , epidemiology and market forecast 2027

1. ACROMEGALY AND GIGANTISM THERAPEUTICS
MARKET INSIGHTS, EPIDEMIOLOGY AND MARKET FORECAST-2027
DelveInsight © 2017 | All rights reserved

2. Acromegaly
The excessive GH comes from benign tumors
on the pituitary
Rare but serious hormonal disorder
Cause - excessive growth hormone (GH) in the body
Serious health complications - type 2 diabetes,
high bp, cardiovascular diseases, and arthritis.
DelveInsight © 2017 | All rights reserved

3. Gigantism
Excessive production of
GH in children leading to
exaggerated bone growth
and an abnormal increase
in height.
Reason - High linear growth
due to excessive action of
insulin like growth factor
I (IGF-I)
(epiphyseal growth plates a
re open during childhood.)
True gigantism is
rare and usually
caused by a pituitary
mammosomatotroph
adenoma
DelveInsight © 2017 | All rights reserved

4. Key Insights
To develop business strategies
by understanding the trends
shaping and driving the global
disease scenario
To understand future market
competition & insightful
review of key market drivers
& barriers
Understanding detailed
global historical and
forecasted disease
epidemiology covering 7 MM
from 2017-2027
To understand the regulatory
scenario in 7 major markets i.e. US,
Europe (Germany, Spain, Italy, France
& UK) and Japan
Disease overview including etiology,
path physiology, symptoms, diagnosis,
disease management & current
treatment options

5. Major Market Players
Chiasma
Camurus
Antisense
Therapeutics
DelveInsight © 2017 | All rights reserved

6. Emerging Therapies
(Chiasma)
Mycapssa
(Antisense Therapeutics)
ATL-1103
(Camurus)
CAM2029
DelveInsight © 2017 | All rights reserved

7. Market Size by Upcoming Therapies in the 7 MM (2016-2027
)
DelveInsight © 2017 | All rights reserved

8. COMPLETE INFORMATION
• For complete Information please click below
Or write to us at
info@delveinsight.com
DelveInsight © 2017 | All rights reserved
CLICK HERE

9. About DelveInsight
DelveInsight, market research and consulting
firm, provides end to end comprehensive
solutions to the Life Science Industry.
Mission
Vision
“Insight across the value chain” to help
organizations make important business
decisions through the use and analysis
of actionable market intelligence
To be the most trusted marketing research
firm & business consulting firm worldwide.
To be a renowned and premier data driven
solution providers among Pharma & Biotech
companies
DelveInsight © 2017 | All rights reserved

10. Consulting
• Asset Prioritization
• Brand Optimization
• Portfolio Expansion
Opportunity Assessment for
• Licensing
• Market Access
• Partnership
Forecasting
• Drug Sales Forecast
• Indication Forecast
• Late Stage Pipeline Analysis
Report Store
Access over 3000+ Reports
• API
• Market & Pipeline
• Indication & Epidemiology
Service Offerings
Competitive analysis
• Primary Analytics
• News-Letters
• Conference Tracking
• Clinical Trials Tracking
Market Intelligence
• Market Size
• Market Dynamics
• Market Assessment
DelveInsight © 2017 | All rights reserved

11. Thank
you
Contact Us:
info@delveinsight.com
+91 -11 -4568 9769
www.delveinsight.com
blog/delveInsight /
twitter/delveInsight
LinkedIn/delveInsight
DelveInsight © 2017 | All rights reserved